Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
González-Roncero FM, Gentil-Govantes MÁ, González-Molina M, Rivero M, Cantarell C, Alarcón A, Franco A, Sánchez-Plumed J, Lampreabe I, Lauzurica R, González E, Romero R, Ruiz-San Millán JC, Osuna A. González-Roncero FM, et al. Among authors: osuna a. Nefrologia. 2012 Jul 17;32(4):446-54. doi: 10.3265/Nefrologia.pre2012.Mar.11024. Nefrologia. 2012. PMID: 22806279 Free article. English, Spanish.
Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age.
Gentil MA, Osuna A, Capdevila L, Rodriguez-Algarra G, Cantarell C, Pereira P, González-Molina M; Spanish Kidney Transplant of Elderly Donor Study Group. Gentil MA, et al. Among authors: osuna a. Transplant Proc. 2003 Aug;35(5):1706-8. doi: 10.1016/s0041-1345(03)00609-2. Transplant Proc. 2003. PMID: 12962766
Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
Osuna A, Gentil MA, Capdevila L, Cantarell C, Mazuecos A, Pereira P, Rodríguez-Algarra G, González-Molina M; Spanish Kidney Transplant of Elderly Donor Study Group. Osuna A, et al. Transplant Proc. 2005 Apr;37(3):1438-40. doi: 10.1016/j.transproceed.2005.02.039. Transplant Proc. 2005. PMID: 15866630 Clinical Trial.
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study.
Porrini E, Moreno JM, Osuna A, Benitez R, Lampreabe I, Diaz JM, Silva I, Domínguez R, Gonzalez-Cotorruelo J, Bayes B, Lauzurica R, Ibernon M, Moreso F, Delgado P, Torres A. Porrini E, et al. Among authors: osuna a. Transplantation. 2008 Apr 27;85(8):1133-8. doi: 10.1097/TP.0b013e31816b16bd. Transplantation. 2008. PMID: 18431233
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C, Calvo Rodríguez M, Poveda JL, Pascual J, Crespo M, Gomez G, Cabello Pelegrin S, Paul J, Lauzurica R, Perez Mir M, Moreso F, Perelló M, Andres A, González E, Fernandez A, Mendiluce A, Fernández Carbajo B, Sanchez Fructuoso A, Calvo N, Suarez A, Bernal Blanco G, Osuna A, Ruiz-Fuentes MC, Melilli E, Montero Perez N, Ramos A, Fernández B, López V, Hernandez D; Better study. Fernandez Rivera C, et al. Among authors: osuna a. Clin Transplant. 2022 Mar;36(3):e14550. doi: 10.1111/ctr.14550. Epub 2021 Dec 17. Clin Transplant. 2022. PMID: 34851532 Free PMC article.
The influence of delayed graft function.
Sola R, Alarcón A, Jiménez C, Osuna A. Sola R, et al. Among authors: osuna a. Nephrol Dial Transplant. 2004 Jun;19 Suppl 3:iii32-7. doi: 10.1093/ndt/gfh1012. Nephrol Dial Transplant. 2004. PMID: 15192133
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.
Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S; GREAT Study Group. Guirado L, et al. Among authors: osuna a. Am J Transplant. 2011 Sep;11(9):1965-71. doi: 10.1111/j.1600-6143.2011.03571.x. Epub 2011 Jun 10. Am J Transplant. 2011. PMID: 21668633 Free article. Clinical Trial.
Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper.
Crespo M, Zárraga S, Alonso Á, Beneyto I, Díaz Corte C, Fernandez Rodriguez AM, Franco A, Hernández D, González-Roncero FM, Jiménez Martín C, Jimeno L, Lauzurica Valdemoros LR, Llorente S, Mazuecos A, Osuna A, Ramos JP, Rodríguez Benot A, Ruiz San Millán JC, Sánchez Fructuoso A, Torregrosa JV, Guirado L; GREAT Study Group and Spanish Network for Research in Renal Diseases (REDINREN, RED16/0009). Crespo M, et al. Among authors: osuna a. Transplantation. 2020 Aug;104(8 Suppl 2):S1-S12. doi: 10.1097/TP.0000000000003270. Transplantation. 2020. PMID: 32658025 No abstract available.
Hyperinsulinemia and hyperfiltration in renal transplantation.
Porrini E, Bayes B, Diaz JM, Ibernon M, Benitez R, Domínguez R, Moreno JM, Delgado P, Lauzurica R, Silva I, Moreso F, Lampreabe I, Arias M, Osuna A, Torres A. Porrini E, et al. Among authors: osuna a. Transplantation. 2009 Jan 27;87(2):274-9. doi: 10.1097/TP.0b013e318191a7d5. Transplantation. 2009. PMID: 19155984
355 results